by Ralf Bartl | Mar 12, 2021 | News
Frankfurt am Main; Crailsheim, March 12, 2021. – GFE and LVL Technologies today announced to strengthening their long cooperation for the current sales and support of PCL’s COVID-19 antigen rapid test, whereas both companies combine their specific core competences to...
by Ralf Bartl | Mar 9, 2021 | News
Frankfurt am Main, March 12, 2021. – GFE announced the CE-IVD approval of its PoET® HIV blood screening NAT test. The PCR kit is used on GFE’s new, fully integrated NAT testing solution, the PoET® System. With this NAT test GFE continues its tradition as a leading...
by Ralf Bartl | Jan 27, 2021 | News
Frankfurt am Main, January 22, 2021. – GFE today announced the CE-IVD approval of its PoET® HCV blood screening NAT test. The PCR kit is used on GFE’s new, fully integrated NAT testing solution, the PoET® System. With this NAT test GFE continues its tradition as...
by Ralf Bartl | Nov 30, 2020 | News
Seoul; Frankfurt am Main, 30. November 2020. – PCL Inc., and GFE today announced their cooperation to promote PCL’s CE-IVD certified “[COV04S] PCL COVID19 Ag Gold Saliva” rapid test in major parts of Europe. This antigen quick test facilitates the sample collection by...
by Ralf Bartl | Nov 23, 2020 | News
Frankfurt am Main, 23. November 2020. – GFE today announced the CE-IVD approval of its PoET® HBV Kit for use with the new, fully integrated NAT testing solution, the PoET® System. With this kit GFE pursues its tradition as a leading supplier of high-quality blood...
